These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 32899608)
21. IRF4 and IRF8 Act in CD11c+ Cells To Regulate Terminal Differentiation of Lung Tissue Dendritic Cells. Bajaña S; Turner S; Paul J; Ainsua-Enrich E; Kovats S J Immunol; 2016 Feb; 196(4):1666-77. PubMed ID: 26746189 [TBL] [Abstract][Full Text] [Related]
22. The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation. Lee LF; Xu B; Michie SA; Beilhack GF; Warganich T; Turley S; McDevitt HO Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15995-6000. PubMed ID: 16247001 [TBL] [Abstract][Full Text] [Related]
23. The Transcription Factors PU.1 and IRF4 Determine Dendritic Cell-Specific Expression of RALDH2. Yashiro T; Yamaguchi M; Watanuki Y; Kasakura K; Nishiyama C J Immunol; 2018 Dec; 201(12):3677-3682. PubMed ID: 30413670 [TBL] [Abstract][Full Text] [Related]
25. Effect of mesenchymal stem cell-derived exosomes on the induction of mouse tolerogenic dendritic cells. Shahir M; Mahmoud Hashemi S; Asadirad A; Varahram M; Kazempour-Dizaji M; Folkerts G; Garssen J; Adcock I; Mortaz E J Cell Physiol; 2020 Oct; 235(10):7043-7055. PubMed ID: 32043593 [TBL] [Abstract][Full Text] [Related]
26. Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes. Hayashi T; Yao S; Crain B; Promessi VJ; Shyu L; Sheng C; Kang M; Cottam HB; Carson DA; Corr M PLoS One; 2015; 10(6):e0129867. PubMed ID: 26076454 [TBL] [Abstract][Full Text] [Related]
27. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Feili-Hariri M; Dong X; Alber SM; Watkins SC; Salter RD; Morel PA Diabetes; 1999 Dec; 48(12):2300-8. PubMed ID: 10580417 [TBL] [Abstract][Full Text] [Related]
28. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells. Sebastián C; Serra M; Yeramian A; Serrat N; Lloberas J; Celada A J Immunol; 2008 May; 180(9):5898-906. PubMed ID: 18424709 [TBL] [Abstract][Full Text] [Related]
29. Expression and Functional Role of TRPV4 in Bone Marrow-Derived CD11c Naert R; López-Requena A; Voets T; Talavera K; Alpizar YA Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295806 [TBL] [Abstract][Full Text] [Related]
30. Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice. Morin J; Faideau B; Gagnerault MC; Lepault F; Boitard C; Boudaly S Clin Exp Immunol; 2003 Dec; 134(3):388-95. PubMed ID: 14632742 [TBL] [Abstract][Full Text] [Related]
31. Adoptive transfer of GRP78-treated dendritic cells alleviates insulitis in NOD mice. Zhou X; Yang M; Lv Y; Li H; Wu S; Min J; Shen G; He Y; Lei P J Leukoc Biol; 2021 Dec; 110(6):1023-1031. PubMed ID: 34643294 [TBL] [Abstract][Full Text] [Related]
32. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Kared H; Masson A; Adle-Biassette H; Bach JF; Chatenoud L; Zavala F Diabetes; 2005 Jan; 54(1):78-84. PubMed ID: 15616013 [TBL] [Abstract][Full Text] [Related]
33. Haploinsufficiency of interferon regulatory factor 4 strongly protects against autoimmune diabetes in NOD mice. Akazawa S; Kobayashi M; Kuriya G; Horie I; Yu L; Yamasaki H; Okita M; Nagayama Y; Matsuyama T; Akbari M; Yui K; Kawakami A; Abiru N Diabetologia; 2015 Nov; 58(11):2606-14. PubMed ID: 26271342 [TBL] [Abstract][Full Text] [Related]
34. miR-22 controls Irf8 mRNA abundance and murine dendritic cell development. Li HS; Greeley N; Sugimoto N; Liu YJ; Watowich SS PLoS One; 2012; 7(12):e52341. PubMed ID: 23251709 [TBL] [Abstract][Full Text] [Related]
35. CCL22-producing CD8α- myeloid dendritic cells mediate regulatory T cell recruitment in response to G-CSF treatment. Layseca-Espinosa E; Korniotis S; Montandon R; Gras C; Bouillié M; Gonzalez-Amaro R; Dy M; Zavala F J Immunol; 2013 Sep; 191(5):2266-72. PubMed ID: 23878314 [TBL] [Abstract][Full Text] [Related]
36. OX40L/Jagged1 cosignaling by GM-CSF-induced bone marrow-derived dendritic cells is required for the expansion of functional regulatory T cells. Gopisetty A; Bhattacharya P; Haddad C; Bruno JC; Vasu C; Miele L; Prabhakar BS J Immunol; 2013 Jun; 190(11):5516-25. PubMed ID: 23630352 [TBL] [Abstract][Full Text] [Related]
37. A defect in bone marrow derived dendritic cell maturation in the nonobesediabetic mouse. Strid J; Lopes L; Marcinkiewicz J; Petrovska L; Nowak B; Chain BM; Lund T Clin Exp Immunol; 2001 Mar; 123(3):375-81. PubMed ID: 11298122 [TBL] [Abstract][Full Text] [Related]
38. M-CSF and GM-CSF regulation of STAT5 activation and DNA binding in myeloid cell differentiation is disrupted in nonobese diabetic mice. Rumore-Maton B; Elf J; Belkin N; Stutevoss B; Seydel F; Garrigan E; Litherland SA Clin Dev Immunol; 2008; 2008():769795. PubMed ID: 19165346 [TBL] [Abstract][Full Text] [Related]
39. Phenotypic alterations in pancreatic lymph node stromal cells from human donors with type 1 diabetes and NOD mice. Postigo-Fernandez J; Farber DL; Creusot RJ Diabetologia; 2019 Nov; 62(11):2040-2051. PubMed ID: 31486854 [TBL] [Abstract][Full Text] [Related]
40. Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice. Steptoe RJ; Ritchie JM; Harrison LC J Immunol; 2002 May; 168(10):5032-41. PubMed ID: 11994455 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]